pharmaceutical investing Gemphire Announces Termination of Phase 2a Clinical Trial of Gemcabene in Pediatric NAFLD
pharmaceutical investing Gemcabene Meets Primary Endpoint in INDIGO-1 Study of Severe Hypertriglyceridemia (SHTG) Patients
Homerun Resources Inc. Receives Joint Support Plan from BNDES and FINEP Indicating Financial Instruments Available to Support Homerun's Business Plan
Radiopharm Theranostics Receives IND approval from US FDA to Initiate Phase I Therapeutic Clinical Study to target B7H3 with Betabart
Allied Critical Metals Launches Allied USA to Expand Tungsten Import and Distribution Operations, Lists on OTCQB, and Receives DTC Eligibility
